79281569 - BACHEM

Information

• Trademark
• 79281569

• Source

• Serial Number

  79281569

• Registration Number

  6748998

• International Classifications

  • 1 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry
  • 5 - Pharmaceutical and veterinary preparations
  • 40 - Treatment of materials
  • 42 - Scientific and technological services and research and design relating thereto

• Filing Date

  December 27, 2019
  5 years ago

• Registration Date

  June 07, 2022
  2 years ago

• Transaction Date

  September 19, 2022
  2 years ago

• Status Date

  June 07, 2022
  2 years ago

• Published for Opposition Date

  February 15, 2022
  3 years ago

• Location Date

  June 07, 2022
  2 years ago

• Status Code

  700

• Current Location

  PUBLICATION AND ISSUE SECTION

  Employee Name

  CIANCI, RYAN MICHAEL

• Attorney Name

  Sarah M. Robertson

  Law Office Assigned Location Code

  M70

• Owners

  • Bachem Holding AG

Case File Statements

• GS0401: Custom manufacture of pharmaceuticals; custom manufacture of biopharmaceuticals; custom manufacturing of peptides; custom manufacturing of proteins; custom manufacturing of oligonucleotides; processing of chemicals; processing of chemical reagents; processing of peptides; processing of proteins; processing of oligonucleotides; processing of medicinal materials; processing of biopharmaceutical materials for others; treatment of biopharmaceutical materials
• GS0051: Chemical reagents for medical or veterinary use; reagents for medical use; peptides for medical use; protein arrays for medical diagnostic use; oligonucleotides for medical use; amino acids for medical use; peptides for pharmaceutical use; synthetic peptides for pharmaceutical use; peptides for veterinary use; amino acids for veterinary use; diagnostic preparations for medical use; diagnostic preparations for veterinary use; biological and pharmaceutical preparations for diagnostic purposes; diagnostic test reagents for medical or veterinary use; peptides for diagnostic purposes; proteins for diagnostic purposes; oligonucleotides for diagnostic purposes; diagnostic kits containing diagnostic agents, preparations and substances for medical use; chemical preparations for the diagnosis of pregnancy; biological and chemical reagents for medical or veterinary use; biological preparations for diagnostic purposes; pharmaceutical preparations against metabolic diseases; pharmaceutical preparations for wound healing; pharmaceutical preparations against genetic diseases; pharmaceutical preparations against neurological diseases; biological reagents for medical use; biological reagents for veterinary use; adjuvants for medical use; adjuvants for veterinary use; anti-bacterial preparations for medical purposes; anti-cancer preparations; antitumor drugs; biopharmaceutical anti-tumor medicines; biopharmaceuticals for the treatment of cancer; anti-diabetic preparations; chemotherapeutics; cosmeceuticals for therapeutic or medical use, namely, medicated soap; dermatological preparations; diagnostic biomarker reagents for medical use; food supplements with cosmetic effect; dietetic preparations adapted for medical use; dietetic preparations adapted for veterinary use; drug delivery agents in the form of coatings for tablets that facilitate the delivery of pharmaceutical preparations; in vitro diagnostic preparations for medical use; medical diagnostic reagents and assays for testing of body fluids; nucleic acid sequences for medical and veterinary use; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing
• GS0011: Chemicals for use in industry and science; chemical preparations for scientific use; chemical preparations for use in industry; industrial chemicals; reagents for research purposes; reagents for scientific use; chemical preparations for scientific use, other than for medical or veterinary use; chemical reagents, other than for medical or veterinary use; chemicals for industry; chemical reagents for scientific use; peptides for use in industry and science; proteins for use in industry and science; oligonucleotides for use in industry and science; oligopeptides for industrial use; proteins for industrial use; proteins for use in manufacture; amino acids for industrial use; amino acids for scientific use; peptide substrates for scientific use; chemical preparations for use in the manufacture of cosmetics; peptides for use in the manufacture of cosmetics; proteins for use in the manufacture of cosmetics; oligonucleotides for use in the manufacture of cosmetics; chemical preparations for use in the production of medicines; chemical preparations for use in the manufacture of pharmaceuticals; peptides for use in the manufacture of pharmaceuticals; proteins for use in the manufacture of pharmaceuticals; oligonucleotides for use in the manufacture of pharmaceuticals; chemical reagents for use in genetic research; chemicals for use in biotechnological manufacturing processes; chemicals for use in biotechnological product development; active chemical ingredients for use in the manufacture of anti-cancer drugs; active chemical ingredients for use in the manufacture of anti-diabetes drugs; active chemical ingredients for use in the manufacture of drugs against metabolic diseases; active chemical ingredients for use in the manufacture of drugs for wound healing; active chemical ingredients for use in the manufacture of drugs against genetic diseases; active chemical ingredients for use in the manufacture of drugs against neurological diseases; amides for use in manufacture; chemical additives for use in the manufacture of cosmetics; chemical additives for use in the manufacture of medicines; chemical additives for use in the manufacture of pharmaceuticals; diagnostic preparations for scientific or research use; diagnostic preparations, other than for medical or veterinary use; diagnostic reagents for scientific or research use; diagnostic reagents, other than for medical or veterinary use; biological preparations for use in industry and science; biological preparations, other than for medical or veterinary use; adjuvants, other than for medical or veterinary purposes; biochemical catalysts; biochemical preparations for scientific use; biochemicals for in vitro and in vivo scientific use; emollients for industrial use; emollients for use in the manufacture of cosmetics; emollients for use in the manufacture of pharmaceuticals; enzyme stabilizers; enzyme substrates; phosphoproteins
• GS0421: Scientific research; chemical research; chemical engineering; product research and development; research and development of new products for others; research and development services in the field of chemistry; research and development in the field of peptides; research and development in the field of proteins; research and development in the field of oligonucleotides; research and development services for the pharmaceutical industry; research and development services in the field of pharmaceutical preparations; research and development services in the field of biochemistry; research and development services in the field of cosmetics; research and development services in the field of diagnostic preparations; research and development services in the field of gene expression systems; research in the fields of chemistry and biology; development of methods of manufacture for peptides, proteins, oligonucleotides, pharmaceuticals, and cosmetics; development of analytic methods for developing for peptides, proteins, oligonucleotides, pharmaceuticals, and cosmetics; scientific laboratory services; chemical analysis; chemical, biochemical, biological and bacteriological research and analysis; analysis in the form of research in the field of molecular biology; conducting of scientific feasibility studies; providing information in the form of preparation of reports relating to scientific research; quality control; product testing; advisory services relating to material testing; consultancy in the field of biochemistry research; consultancy in the field of chemistry research; consultancy in the field of scientific and industrial research; consultancy relating to laboratory testing research; consulting services in the field of recombinant DNA technology research

Case File Event Statements

• 9/19/2022 - 2 years ago

  41 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS

• 9/19/2022 - 2 years ago

  40 - FINAL DISPOSITION PROCESSED Type: FIMP

• 9/7/2022 - 2 years ago

  39 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR

• 6/7/2022 - 2 years ago

  38 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC

• 6/7/2022 - 2 years ago

  37 - REGISTERED-PRINCIPAL REGISTER Type: R.PR

• 4/29/2022 - 2 years ago

  36 - ELECTRONIC RECORD REVIEW COMPLETE Type: FIXD

• 4/1/2022 - 2 years ago

  35 - ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Type: ERRR

• 2/15/2022 - 3 years ago

  34 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB

• 2/15/2022 - 3 years ago

  33 - PUBLISHED FOR OPPOSITION Type: PUBO

• 2/13/2022 - 3 years ago

  32 - NOTIFICATION PROCESSED BY IB Type: GPNX

• 1/26/2022 - 3 years ago

  31 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 1/26/2022 - 3 years ago

  30 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R

• 1/26/2022 - 3 years ago

  29 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP

• 1/11/2022 - 3 years ago

  28 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA

• 1/8/2022 - 3 years ago

  27 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 1/7/2022 - 3 years ago

  26 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 1/7/2022 - 3 years ago

  25 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 9/19/2021 - 3 years ago

  24 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX

• 9/1/2021 - 3 years ago

  23 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS

• 9/1/2021 - 3 years ago

  22 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR

• 7/7/2021 - 3 years ago

  21 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN

• 7/7/2021 - 3 years ago

  20 - NON-FINAL ACTION E-MAILED Type: GNRT

• 7/7/2021 - 3 years ago

  19 - NON-FINAL ACTION WRITTEN Type: CNRT

• 5/25/2021 - 3 years ago

  18 - LIMITATION FROM THE IB - REQUEST EXAM REVIEW Type: LIME

• 2/24/2021 - 4 years ago

  17 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN

• 2/24/2021 - 4 years ago

  16 - FINAL REFUSAL E-MAILED Type: GNFR

• 2/24/2021 - 4 years ago

  15 - FINAL REFUSAL WRITTEN Type: CNFR

• 1/29/2021 - 4 years ago

  14 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME

• 1/29/2021 - 4 years ago

  13 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA

• 1/28/2021 - 4 years ago

  12 - ASSIGNED TO LIE Type: ALIE

• 11/27/2020 - 4 years ago

  11 - LIMITATION OF GOODS RECEIVED FROM IB Type: LIMG

• 10/19/2020 - 4 years ago

  10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA

• 5/9/2020 - 4 years ago

  9 - REFUSAL PROCESSED BY IB Type: RFNT

• 4/18/2020 - 4 years ago

  8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS

• 4/18/2020 - 4 years ago

  7 - REFUSAL PROCESSED BY MPU Type: RFRR

• 4/3/2020 - 4 years ago

  6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR

• 4/3/2020 - 4 years ago

  5 - APPLICATION FILING RECEIPT MAILED Type: MAFR

• 4/2/2020 - 4 years ago

  4 - NON-FINAL ACTION WRITTEN Type: CNRT

• 3/30/2020 - 4 years ago

  3 - ASSIGNED TO EXAMINER Type: DOCK

• 3/30/2020 - 4 years ago

  2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS

• 3/26/2020 - 4 years ago

  1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR